Health ❯ Healthcare ❯ Clinical Trials ❯ Randomized Controlled Trials

Beta-Blockers

Beta-Blockers After Heart Attack Show Mixed Results, Benefit Seen at 40–49% EF

Guideline decisions now hinge on EF‑stratified effects highlighted at ESC Congress 2025.